(Q57306293)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

review article

1 reference

title

Mild cognitive impairment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

1 reference

cognitive dysfunction

1 reference

mild cognitive impairment

inferred from title

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Mony J de Leon

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Howard Feldman

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

19

Bengt Winblad

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

7

Sylvie Belleville

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

16

Philip Scheltens

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

4

Ronald C Petersen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1

Serge Gauthier

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Michael Zaudig

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Karen Ritchie

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Karl Broich

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Howard Chertkow

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Mary Ganguli

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Mary C Tierney

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Peter Whitehouse

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Henry Brodaty

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

David Bennett

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Jeffrey L Cummings

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Harald Hampel

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

International Psychogeriatric Association Expert Conference on mild cognitive impairment

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

English

0 references

publication date

1 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

367

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

9518

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

1262-1270

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

A new clinical scale for the staging of dementia.

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

The Global Deterioration Scale for assessment of primary degenerative dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Mild cognitive impairment in the elderly: predictors of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Prevalence and severity of cognitive impairment with and without dementia in an elderly population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Mild cognitive impairment as a diagnostic entity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Mild cognitive impairment, amnestic type: an epidemiologic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Neuropsychological prediction of decline to dementia in nondemented elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Vitamin E and donepezil for the treatment of mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Mild Cognitive Impairment Can Be Distinguished From Alzheimer Disease and Normal Aging for Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Anticholinergic side-effects of drugs in elderly people

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Vascular cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Distinctive clinical features of mild cognitive impairment with subcortical cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Mild cognitive impairment represents early-stage Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Mild cognitive impairment as a clinical entity and treatment target

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Amnestic MCI or prodromal Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Behavioral symptoms in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Classification criteria for mild cognitive impairment: a population-based validation study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Prediction of transition from cognitive impairment to senile dementia: a prospective, longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Stability of the preclinical episodic memory deficit in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

1 reference

7 January 2021

Contribution of informant and patient ratings to the accuracy of the mini-mental state examination in predicting probable Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Psychiatric symptomatology and prodromal Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Mild cognitive impairment in older people.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Functional impairment in instrumental activities of daily living: an early clinical sign of dementia?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Functional deficits in patients with mild cognitive impairment: prediction of AD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

The Alzheimer's disease activities of daily living international scale (ADL-IS).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Instrumental activities of daily living: a stepping-stone towards Alzheimer's disease diagnosis in subjects with mild cognitive impairment?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Equilibrium and limb coordination in mild cognitive impairment and mild Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Early marker for Alzheimer's disease: the atrophic hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Hippocampal formation glucose metabolism and volume losses in MCI and AD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Quantitative EEG correlates of cognitive deterioration in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Decreased EEG synchronization in Alzheimer's disease and mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

MRI predictors of risk of incident Alzheimer disease: a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

CSF markers for incipient Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Mild cognitive impairment is not a clinical entity and should not be treated

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Mild cognitive impairment--no benefit from vitamin E, little from donepezil

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Long-term improvements in cognitive performance through computer-assisted cognitive training: a pilot study in a residential home for older people

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Effects of cognitive training interventions with older adults: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Caregiving burden and psychiatric morbidity in spouses of persons with mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Antiaging medicine and mild cognitive impairment: practice and policy issues for geriatrics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Aging-Associated Cognitive Decline

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

The Gospel Oak Study stage IV: the clinical relevance of subjective memory impairment in older people.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Association of subjective memory complaints with subsequent cognitive decline in community-dwelling elderly individuals with baseline cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

Subjective memory complaints in aging are associated with elevated cortisol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968542-5

7 January 2021

10.1016/S0140-6736(06)68542-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16631882%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference